Two by two comparison tables for calculation of sensitivity, specificity and diagnostic accuracy for genomic aberrations in KRAS and BRAF between tumor tissues sequenced at Samsung Medical Center and blinded cfDNA analysis at Guardant Health for advanced colorectal cancer and BRAF for advanced melanoma patients. This evidence concerns the gene BRAF and neoplasm.